A new breast cancer drug is being tested in Manchester, that could be a lifeline to women with the most aggressive form of the disease.
The drug, known as T-DM1, is designed to slow the progress of The treatment increases the survival time of some patients by almost six months.
It also reduces side effects such as hair loss, and gives sufferers a better quality of life
More top news
Alfie Jones is cheered on by school pals as he gets out of his wheelchair to compete in the race
Plenty of rain, not much sunshine! Kerrie has the latest...
Consultation launched to reduce the number of front counters at police stations across Lancashire